Macquarie Group’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,834
Closed -$25K 2456
2022
Q3
$25K Sell
1,834
-3,361
-65% -$45.8K ﹤0.01% 2137
2022
Q2
$23K Hold
5,195
﹤0.01% 2269
2022
Q1
$25 Hold
5,195
﹤0.01% 2334
2021
Q4
$39K Hold
5,195
﹤0.01% 2238
2021
Q3
$29K Hold
5,195
﹤0.01% 2371
2021
Q2
$34K Hold
5,195
﹤0.01% 2244
2021
Q1
$42K Sell
5,195
-1,593
-23% -$12.9K ﹤0.01% 2121
2020
Q4
$44K Hold
6,788
﹤0.01% 2073
2020
Q3
$24K Hold
6,788
﹤0.01% 2131
2020
Q2
$31K Buy
+6,788
New +$31K ﹤0.01% 2049
2019
Q4
Sell
-212
Closed -$1K 1970
2019
Q3
$1K Buy
+212
New +$1K ﹤0.01% 1870
2019
Q2
Sell
-350,000
Closed -$949K 1885
2019
Q1
$949K Sell
350,000
-300,000
-46% -$813K ﹤0.01% 1205
2018
Q4
$3.12M Hold
650,000
0.01% 858
2018
Q3
$6.16M Sell
650,000
-483,000
-43% -$4.57M 0.01% 738
2018
Q2
$11M Buy
1,133,000
+3,000
+0.3% +$29.2K 0.02% 616
2018
Q1
$11.9M Sell
1,130,000
-17,300
-2% -$182K 0.02% 582
2017
Q4
$7.35M Buy
1,147,300
+297,300
+35% +$1.91M 0.01% 705
2017
Q3
$6.5M Hold
850,000
0.01% 696
2017
Q2
$6.04M Buy
850,000
+150,000
+21% +$1.07M 0.01% 699
2017
Q1
$2.71M Hold
700,000
﹤0.01% 895
2016
Q4
$1.43M Sell
700,000
-230,000
-25% -$469K ﹤0.01% 1066
2016
Q3
$2.49M Sell
930,000
-930,000
-50% -$2.49M ﹤0.01% 897
2016
Q2
$5.73M Buy
1,860,000
+1,380,000
+288% +$4.25M 0.01% 845
2016
Q1
$4.09M Buy
480,000
+50,000
+12% +$426K 0.01% 761
2015
Q4
$5.84M Hold
430,000
0.01% 672
2015
Q3
$4.13M Hold
430,000
0.01% 776
2015
Q2
$6.18M Hold
430,000
0.01% 686
2015
Q1
$3.85M Buy
430,000
+140,000
+48% +$1.25M 0.01% 826
2014
Q4
$1.77M Hold
290,000
﹤0.01% 1049
2014
Q3
$3.07M Buy
290,000
+25,000
+9% +$265K 0.01% 854
2014
Q2
$3.14M Sell
265,000
-3,077
-1% -$36.5K 0.01% 869
2014
Q1
$4M Buy
268,077
+203,847
+317% +$3.04M 0.01% 741
2013
Q4
$942K Buy
64,230
+5,490
+9% +$80.5K ﹤0.01% 1149
2013
Q3
$1M Buy
58,740
+2,950
+5% +$50.2K ﹤0.01% 1167
2013
Q2
$926K Buy
+55,790
New +$926K ﹤0.01% 1167